Curosurf

Entity type image
Type: Product
Name: Curosurf
First reported May 22 2013 - Updated May 22 2013 - 1 reports

Ascent Pharmahealth Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile - New Study Released

(live-PR.com) - Ascent Pharmahealth Limited (Ascent) is a pharmaceutical company, based in Australia. The company manufactures and supplies pharmaceutical and skincare products. Its products include anti infectious, over the counter products, cardiovascular, ... [Published Live-PR.com - May 22 2013]
First reported May 09 2013 - Updated May 10 2013 - 2 reports

Cornerstone Therapeutics Management Discusses Q1 2013 Results - Earnings Call Transcript

8:30 AM ETOperatorLadies and gentlemen, thank you for standing by, and welcome to the Cornerstone Therapeutics First Quarter 2013 Financial Results Call. [Operator Instructions] As a reminder, today's call is being recorded. With that said, I'll turn ... [Published Seeking Alpha - May 09 2013]
First reported Dec 21 2012 - Updated Dec 21 2012 - 1 reports

New Curosurf Contract Terms Are Good News For Cornerstone Therapeutics

ByPropThink: By Jake King Cornerstone Therapeutics (NASDAQ: CRTX ) has renegotiated a distribution agreement with partner and majority shareholder Chiesi Farmaceutici, an Italian pharmaceutical company, which according to the company, should improve ... [Published Healthcare Sector and Stocks Analysis from Seek ... - Dec 21 2012]
First reported Dec 04 2012 - Updated Dec 05 2012 - 1 reports

Galena Reaches Deal with Teva, IRIDEX Wins FDA & CE Approval: Healthcare Business Recap

Galena Biopharma  has reached an agreement with a subsidiary of  Teva Pharmaceutical Industries Limited  ( NYSE:TEVA ) for the commercialization of NeuVax” (nelipepimut-S or E75) in Israel, according to a Tuesday press release. The former is a biotech ... [Published Wall St. Cheat Sheet - Dec 04 2012]

Quotes

...By tracking the size and price of each montha'a "s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin."
...We believe that strategy is starting to really pay off," said Craig A Collard, Cornerstone's Chief Executive Officer. "Increased sales of our products in addition to improved gross margins and profitability show that our strategy is working. We are confident that Cornerstone is well positioned for continued growth."
...Additionally, the amendment provides "certain modifications to the financial terms of the Distribution Agreement, including supply price and commercial incentives." Not only will Cornerstone see better economics following the changes, but the improving margins signal that Chiesi, which has been increasing an already...

More Content

All (9) | News (5) | Reports (2) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Ascent Pharmahealth Limited - Pharmaceuticals &... [Published Live-PR.com - May 22 2013]
CRTX, ENS, CNC, ABG, XRTX, FBR Are Seasonally R... [Published Individual.com - May 22 2013]
Cornerstone Therapeutics Management Discusses Q... [Published Seeking Alpha - May 09 2013]
Cornerstone Therapeutics Reports First Quarter ... [Published Citybizlist - May 09 2013]
MDT, CRTX, IPCC, GTIV, HCN, STON Expected To Be... [Published Individual.com - May 01 2013]
CGW, V, VPU, INTX, SLG, CRTX Are Seasonally Rip... [Published Individual.com - Apr 17 2013]
Deals Of The Week Wonders What Merck's Latest B... [Published The IN VIVO Blog - Feb 22 2013]
New Curosurf Contract Terms Are Good News For C... [Published Healthcare Sector and Stocks Analysis from Seek ... - Dec 21 2012]
Galena Reaches Deal with Teva, IRIDEX Wins FDA ... [Published Wall St. Cheat Sheet - Dec 04 2012]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Deals Of The Week Wonders What Merck's Latest B... [Published The IN VIVO Blog - Feb 22 2013]
Ever since Merck jumped into the biosimilar field in 2008 with a ferocious go get ’em attitude more fitting of an NFL tackle than a big pharma, we’ve been following their progress – and then lack of progress – closely. Back when most pharmaceutical ...
Galena Reaches Deal with Teva, IRIDEX Wins FDA ... [Published Wall St. Cheat Sheet - Dec 04 2012]
Galena Biopharma  has reached an agreement with a subsidiary of  Teva Pharmaceutical Industries Limited  ( NYSE:TEVA ) for the commercialization of NeuVax” (nelipepimut-S or E75) in Israel, according to a Tuesday press release. The former is a biotech ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.